FDA approves IPL device to manage dry eye disease
Patented Lumenis Optimal Pulse Technology (OPT) becomes the first IPL approved for management of dry eye disease due to MGD, and Lumenis launches OptiLight.
Explore Other Resources
PB-00038930 Rev A